-transparent.png){kind=logo}
A review of 78 previously untreated patients with bidimensionally measurable metastatic bladder cancer who were entered into a series of studies of cytotoxic chemotherapy has shown that complete response occurred in 1 of 23 patients receiving methotrexate, none of 15 receiving cisplatin, none of 20 receiving the platinum analogue carboplatin and 3 (2 with histological confirmation) of 20 receiving methotrexate in combination with cisplatin. WHO/UICC performance status 3 and 4, though a prediction of lower response, did not provide a means for excluding patients who might benefit from chemotherapy. Studies using serial cytology showed that 5 of 8 responders according to standard criteria had complete loss of malignant cells from the urine compared with none of 10 non-responders and there was a suggestion that duration of response was longer in those whose urine was negative for malignant cells than in those which remained positive.
R T Oliver, and
H K Kwok, and
W J Highman, and
J Waxman
August 1997,
The Journal of urology,
R T Oliver, and
H K Kwok, and
W J Highman, and
J Waxman
July 1986,
Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
R T Oliver, and
H K Kwok, and
W J Highman, and
J Waxman
October 1992,
Cancer,
R T Oliver, and
H K Kwok, and
W J Highman, and
J Waxman
January 1996,
Tumori,
R T Oliver, and
H K Kwok, and
W J Highman, and
J Waxman
January 2004,
The oncologist,
R T Oliver, and
H K Kwok, and
W J Highman, and
J Waxman
March 1990,
Urology,
R T Oliver, and
H K Kwok, and
W J Highman, and
J Waxman
January 1992,
Cancer chemotherapy and pharmacology,
R T Oliver, and
H K Kwok, and
W J Highman, and
J Waxman
April 1987,
The Journal of urology,
R T Oliver, and
H K Kwok, and
W J Highman, and
J Waxman
January 1990,
Journal of cancer research and clinical oncology,
R T Oliver, and
H K Kwok, and
W J Highman, and
J Waxman
February 2001,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
